Stock screenerAll disclosures →
EDGAR →
CANF
Conviction 51HealthcareScan · Thu, Jun 25, 2026CANF$3.00+0.33%
ResistanceSupportVol 14Vol MA14 37.6K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Can-Fite BioPharma Ltd.www.canfite.com ↗
Price3.00
Change+0.33%
Gap-1.00%
Rel volume2.31×
Avg volume36.42K
Avg $ vol111.1K
SMA 203.05
SMA 503.16
SMA 2002.34
Price vs 50-5.07%
Price vs 200+28.09%
MA stackmixed
50/200 cross—
Supertrendup · 2.74
RSI (14)45
MACD hist0.01
MACD crossbull · 3d
Stoch %K / %D46 / 46
ADX (14)15
+DI / −DI20 / 16
RSI divergence—
MACD divergence—
ATR %+6.33%
ADR %5.17%
52w high6.02
52w low0.1715
From 52w high-50.17%
Above 52w low+1649.27%
New 52w highNo
SqueezeOn · 1d
Bollinger width18.96%
%B0.41
Donchian pos28.13%
Donchian high3.46
Donchian low2.82
AVWAP (52w high)5.52
vs AVWAP high-45.68%
AVWAP (52w low)4.47
vs AVWAP low-32.86%
OBV trendFlat
Chaikin MF (20)-0.36
Today vs 20d2.31×
Avg vol (14d)37.6K
Avg vol (20d)36.42K
Avg $ vol (20d)111.1K
Market cap7.86M
RS 3m (vs SPY)-16.73%
RS 6m (vs SPY)+1078.30%
RS line new highNo
Trend template5/8
Technical rank66.3
1 week-0.99%
1 month-12.79%
3 months-7.12%
6 months+1125.99%
1 year+183.02%
YTD+1263.64%
P/E—
P/B1.40
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current3.46
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value2.33M
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeNYSE
Shares out—
Employees5
ListedMon, Sep 10, 2012
Free float—
Float %—
Short interest67.83K
Days to cover3.1d
Short volume33.5%
Squeeze score50 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction51 / 100
Pattern quality—
Tech rank66.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.79
Support2.96
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in CANF
No recent disclosed trades by Congress in CANF. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CANF · 2 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Farbstein Motti CEO, CFO and COO · Options to Purchase Ordinary Shares · 2026-06-04 | Grant | 24K | $0 | 2026-06-04 | 2026-06-08 |
Fishman Pnina Chief Scientific Officer · Options to Purchase Ordinary Shares · 2026-06-04 | Grant | 24K | $0 | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in CANF · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.